2026 | 2025 | 2024 | 2023 | 2022

2025

February 13, 2025

Annie Clurman and Sara Pernikoff presenting our abstract “RSV in HCT recipients: Clinical and Humoral Risk Factors for Infection” in Hawaii at the Tandem 2025 meeting of the American Society for Transplantation and Cellular Therapy. Great discussion with Filipo Milano from Fred Hutch and Oriana Miltiadous from Sloan Kettering

2024

November 2024

Check out our new collaborative effort with Andrew McGuire and Warren Phipps to take on Kaposi sarcoma-associated herpes virus.

October 16th, 2024

Hannah Lewis presented for the Fred Hutch B-Cell Interest Group "An antigen-agnostic screen to develop broadly protective antibodies for immunotherapy against human cytomegalovirus."

August 2024

Congrats Kristen on presenting your research on quantitative PCR detection of human metapneumovirus at the Fred Hutch Summer Undergraduate Research Program. Shout out to Sara for being a great co-mentor. And make sure to check out what Kristen McLean is working on in this Fred Hutch Video. 

• “Lea Kipnis presents her poster, “Can Modifications in the Antibody Fc Domain Increase the Therapeutic Efficacy of a Cross-Neutralizing Antibody against RSV and HMPV?”, at the University of Washington Undergraduate Research Symposium. Well done, Lea. Shout out to Evelyn and Matt for being awesome teachers.

April 2024

• Boonyaratanakornkit Lab has received a 2024 Evergreen Pilot Award: Development of an Antigen-Agnostic Approach to Isolate Protective Antibodies to Human Cytomegalovirus.

2023

October 31, 2023

• Welcome Hannah Lewis who is joining the lab as our very first post-doctoral fellow.

August 2023

• Celebration of the lab's 0th birthday (baby lab shower) at the Fred Hutch. Go team!

Allison Kim presenting her work "Exploring the kinetics of Fc mutated Antibodies" as part of the Infectious Disease Sciences Summer Scholars Internship Program.

May 2023

• Welcome Evelyn Harris and Ren Ikeda to the lab! Learn more about Evelyn and Ren.

• The Boonyaratanakornkit Lab in collaboration with the Boeckh/Waghmare groups, GSK, and Vir Biotechnology win the best oral abstract award at the International Society for Influenza and Other Respiratory Viruses, Antivirals Group Meeting, in Seattle.

2022

October 2, 2022

• Maddi presents her poster on "Protection against RSV and HPIV3 co-infections using an antibody cocktail" at the RSV 2022 Symposium in Belfast, Ireland.
• Jim is awarded best oral presentation at the RSV 2022 Symposium in Belfast, Ireland.

September 1, 2022

• Farewell and congrats to our structural biology collaborator Justas Rodarte in the Pancera Lab who will be starting graduate school in immunology at the University of Washington.
• Welcome Sara Pernikoff to the lab! Learn more about Sara.

August 13, 2022

• Jim and Maddi ride and volunteer in Obliteride to support cancer and infectious disease research at Fred Hutch.

July 8, 2022

• Jim appears on King5 news to talk about the role of the Fred Hutch Obliteride in supporting cancer and infectious disease research.
  • View King5 news clip

June 26, 2022

• Our preprint on cross-protective antibodies to RSV, HMPV, and parainfluenza viruses is posted on BioRxiv. Check it out!    

June 17, 2022

• We have an open position for a research technician! Check out our Connect page for more information on career opportunities.
  • Research technician level II-III
  • Research technician level I-II

June 3, 2022

• Our collaborator Justas Rodarte in the Pancera Group presents structural data on our cross-neutralizing parainfluenza antibody at the Keystone Symposia on Progress in Vaccine Development for Infectious Diseases in Breckenridge, Colorado.